Korobko V G, Davydov I V, Dobrynin V N, Pustoshilova N M, Lebedev L R, Gileva I P, Petrenko V A
Bioorg Khim. 1993 Apr;19(4):414-9.
Using the oligonucleotide directed mutagenesis, a human lymphotoxin (TNF beta) mutant gene lacking 21 N-terminal codons has been obtained. Recombinant plasmid pLT21 for expression of the mutant gene has been constructed. The mutant gene in the plasmid was placed under control of a tandem of constitutive promoters from coliphage T7. A simple procedure for isolation of recombinant protein was developed. The procedure allows to obtain the highly purified biologically active mutant protein with a good yield. During biosynthesis the recombinant protein undergoes a posttranslational processing resulted in the cleavage of N-terminal methionine and leucine residues.
利用寡核苷酸定向诱变技术,获得了一个缺失21个N端密码子的人淋巴毒素(TNFβ)突变基因。构建了用于表达该突变基因的重组质粒pLT21。质粒中的突变基因置于来自噬菌体T7的串联组成型启动子的控制之下。开发了一种简单的重组蛋白分离方法。该方法能够以良好的产率获得高度纯化的具有生物活性的突变蛋白。在生物合成过程中,重组蛋白经历了翻译后加工,导致N端甲硫氨酸和亮氨酸残基的切割。